Home/ Supplements/ Melatonin/ De-Stress+Snooze

De-Stress+Snooze

product on market Gummy or Jelly Stressballs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Melatonin is supported by strong evidence for reducing sleep onset latency and improving sleep quality. The herbal blend contains botanical ingredients with limited clinical data regarding their specific efficacy for stress reduction. Overall, these components are generally recognized as safe for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for De-Stress+Snooze
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Gummy(ies)
Serving Size
23
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Sodium
15 mg (1% DV)
2 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)
Stressballs Snooze Herbal Blend
230 mg

Other Ingredients

Corn Syrup Water Sugar hydrogenated Coconut Oil Pectin Natural Flavors Maltodextrin Citric Acid Sodium Potassium Tartrate Soy Lecithin Sodium Citrate Malic Acid Sodium Polyphosphate Blue 2
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two gummies 30 minutes before bedtime. Use nightly for stronger effect, as results improve over time. Allow more than 6 hours of sleep.

Warnings & Precautions

Warnings: Consult a healthcare professional: before use if below 18 yrs in age; if you are experiencing long-term sleep difficulties; before use if pregnant, attempting to become pregnant or nursing; those with a medical condition, those taking medication, and those who have chronic diseases; if taking sedatives, tranquilizers or any other sleep aid.

Warnings: Consult a healthcare professional: before use if below 18 yrs in age; if you are experiencing long-term sleep difficulties; before use if pregnant, attempting to become pregnant or nursing; those with a medical condition, those taking medication, and those who have chronic diseases; if taking sedatives, tranquilizers or any other sleep aid.

Do not drive or operate machinery when taking melatonin. Do not use when consuming alcohol.

Keep out of reach of children

Contains: Soy, tree nuts (coconut)

Formulation Notes

Non-habit forming No next day grogginess

Drug free, gluten free, lactose free, & gelatin free

Ashwagandha Melatonin Lavender

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 3700 74370 5
DSLD Entry Date2022-11-22
Product TypeOther Combinations
FormGummy or Jelly
DSLD ID278087
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.